EDGe Surgical closed a US $4MM round of Series A financing to fund commercialization of both its single-use electronic depth gauge and future products.
DiscGenics received approval in Japan to advance into clinical studies of IDCT allogeneic injectible disc cell therapy for the treatment of lumbar degenerative disc disease.